12mon MSN
Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.
AbbVie has partnered with Neomorph to develop new molecular glue degraders (MGDs) for multiple targets across oncology and ...
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback